Skip to main content

Tarsus Pharmaceuticals, Inc.

TARS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001819790

In the last 90 days, Tarsus Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 6 sales; 256 institutions reported holding it in 13F filings for Q2 2026, worth $2.98B in total; no superinvestor holds it.

13F holders, Q2 2021

Institutional positions in Tarsus Pharmaceuticals, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
44
+3 vs. Q1 2021
Shares held
13.1M
+299.8K (+2.3%) vs. Q1 2021
Total value
$378.5M
−$31.8M (−7.8%) vs. Q1 2021
New holders
10
17 more added
Sold out
7
9 more reduced

Compare with Q1 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TARS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2021: 44 institutions
Q1 2021: 41 institutionsQ2 2021: 44 institutionsQ3 2021: 44 institutionsQ4 2021: 43 institutionsQ1 2022: 51 institutionsQ2 2022: 73 institutionsQ3 2022: 75 institutionsQ4 2022: 69 institutionsQ1 2023: 74 institutionsQ2 2023: 92 institutionsQ3 2023: 105 institutionsQ4 2023: 116 institutionsQ1 2024: 157 institutionsQ2 2024: 148 institutionsQ3 2024: 162 institutionsQ4 2024: 195 institutionsQ1 2025: 195 institutionsQ2 2025: 205 institutionsQ3 2025: 220 institutionsQ4 2025: 246 institutionsQ1 2026: 253 institutionsQ2 2026: 256 institutions
Value heldQ2 2021: $378.5M
Q1 2021: $410.4MQ2 2021: $378.5MQ3 2021: $277.4MQ4 2021: $294.2MQ1 2022: $222.2MQ2 2022: $291.7MQ3 2022: $350.8MQ4 2022: $301.0MQ1 2023: $252.1MQ2 2023: $387.3MQ3 2023: $529.4MQ4 2023: $652.0MQ1 2024: $1.43BQ2 2024: $1.09BQ3 2024: $1.43BQ4 2024: $2.23BQ1 2025: $2.26BQ2 2025: $1.87BQ3 2025: $2.67BQ4 2025: $3.61BQ1 2026: $3.17BQ2 2026: $2.98B
Institutions holding TARS and their total value by quarter
QuarterHoldersValue
Q2 2026256$2.98B
Q1 2026253$3.17B
Q4 2025246$3.61B
Q3 2025220$2.67B
Q2 2025205$1.87B
Q1 2025195$2.26B
Q4 2024195$2.23B
Q3 2024162$1.43B
Q2 2024148$1.09B
Q1 2024157$1.43B
Q4 2023116$652.0M
Q3 2023105$529.4M
Q2 202392$387.3M
Q1 202374$252.1M
Q4 202269$301.0M
Q3 202275$350.8M
Q2 202273$291.7M
Q1 202251$222.2M
Q4 202143$294.2M
Q3 202144$277.4M
Q2 202144$378.5M
Q1 202141$410.4M

Institutions, Q2 2021

Shares, value and share of portfolio for each institution holding Tarsus Pharmaceuticals, Inc.; share changes are against Q1 2021.

Institutions holding TARS in Q2 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Vivo Capital, LLC2,987,331$86.6M3.75%−257,704−7.9%Reduced
RTW Investments, LP2,013,601$58.4M0.88%−450,000−18.3%Reduced
Cormorant Asset Management, LP1,514,269$43.9M1.71%−200,000−11.7%Reduced
Frazier Management LLC1,417,157$41.1M3.79%−500,000−26.1%Reduced
Perceptive Advisors LLC1,296,416$37.6M0.49%00.0%Unchanged
TimesSquare Capital Management, LLC686,705$19.9M0.16%+234,805+52.0%Added
Cowen and Company, LLC514,289$14.9M0.79%+514,289New
Jefferies Group LLC442,993$12.8M0.22%+442,993New
BlackRock Inc.438,356$12.7M0.00%+98,559+29.0%Added
Vanguard Group Inc426,045$12.3M0.00%+153,055+56.1%Added
Sands Capital Management, LLC260,000$7.54M0.01%00.0%Unchanged
Ensign Peak Advisors, Inc200,000$5.80M0.01%00.0%Unchanged
Ghost Tree Capital, LLC170,000$4.93M1.54%+170,000New
Geode Capital Management, LLC125,521$3.64M0.00%+23,712+23.3%Added
State Street Corp119,141$3.45M0.00%+18,757+18.7%Added
Northern Trust Corp79,635$2.31M0.00%+12,600+18.8%Added
Altium Capital Management LP70,573$2.04M0.47%+70,573New
Charles Schwab Investment Management Inc46,573$1.35M0.00%+4,950+11.9%Added
J. Goldman & Co LP33,751$978.0K0.06%+33,751New
Invesco Ltd.30,428$882.0K0.00%+1,169+4.0%Added
Goldman Sachs Group Inc26,880$779.0K0.00%−2,114−7.3%Reduced
Nuveen Asset Management, LLC25,723$745.0K0.00%+10,891+73.4%Added
SG Americas Securities, LLC22,977$666.0K0.00%+22,977New
Bank of New York Mellon Corp21,573$625.0K0.00%+6,099+39.4%Added
Pura Vida Investments, LLC16,686$484.0K0.03%+16,686New
California State Teachers Retirement System11,644$337.0K0.00%+2,345+25.2%Added
New York State Common Retirement Fund9,353$271.0K0.00%+3,453+58.5%Added
State of Wisconsin Investment Board8,600$249.0K0.00%00.0%Unchanged
Morgan Stanley8,282$241.0K0.00%+8,282New
Hunter Perkins Capital Management, LLC7,780$225.0K0.04%00.0%Unchanged
Virtus ETF Advisers LLC6,319$183.0K0.08%+6,319New
Deutsche Bank AG5,574$161.0K0.00%+1,638+41.6%Added
JPMorgan Chase & Co5,162$150.0K0.00%−5,750−52.7%Reduced
American International Group, Inc.4,724$137.0K0.00%+1,098+30.3%Added
STRS Ohio2,100$60.0K0.00%+600+40.0%Added
Bank of America Corp1,960$57.0K0.00%−7,277−78.8%Reduced
Tower Research Capital LLC (TRC)1,173$34.0K0.00%+806+219.6%Added
Legal & General Group Plc818$24.0K0.00%+179+28.0%Added
Royal Bank of Canada577$17.0K0.00%−893−60.7%Reduced
Ameritas Investment Partners, Inc.515$15.0K0.00%00.0%Unchanged
Citigroup Inc401$12.0K0.00%−12−2.9%Reduced
Spire Wealth Management100$3.00K0.00%00.0%Unchanged
Signaturefd, LLC27$1.00K0.00%+27New
Tucker Asset Management LLC4$1160.00%00.0%Unchanged
Millennium Management LLC0$00.00%−84,854−100.0%Sold out
HighVista Strategies LLC0$00.00%−21,084−100.0%Sold out
Endurant Capital Management LP0$00.00%−14,143−100.0%Sold out
Woodline Partners LP0$00.00%−12,310−100.0%Sold out
UBS Group AG0$00.00%−2,496−100.0%Sold out
Wells Fargo & Company0$00.00%−1,941−100.0%Sold out
Bank of Montreal0$00.00%−192−100.0%Sold out